Please wait a minute...
Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology)  2009, Vol. 10 Issue (11): 791-795    DOI: 10.1631/jzus.B0920217
Biomedicine     
Decreased serum prohepcidin concentration in patients with polycythemia vera
Justyna KWAPISZ, Ewa ŻEKANOWSKA, Joanna JASINIEWSKA
Department of Pathophysiology, Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Poland
Download:     PDF (0 KB)     
Export: BibTeX | EndNote (RIS)      

Abstract  Objective: Iron deficiency is a common complication in patients with polycythemia vera (PV). Hepcidin is a principal regulator of iron homeostasis. The aim of our study was to assess prohepcidin, a hepcidin precursor, and other iron status parameters in the serum of PV patients. Methods: The study was performed in 60 patients (F/M 26/34) aged 38~84 (66±10) years. The control group consisted of 20 healthy volunteers, age and sex matched. The following parameters were determined in blood serum samples: prohepcidin concentration, iron content, unsaturated iron binding capacity (UIBC), total iron binding capacity (TIBC), transferrin saturation (TfS), and concentrations of ferritin and soluble transferrin receptor (sTfR). Results: All PV patients showed significantly lower levels of prohepcidin, higher levels of sTfR and TIBC compared to the control group. 40% of the patients from the study group showed concentrations of ferritin below the normal range and significantly lower levels of serum iron and TfS, and significantly higher levels of sTfR, UIBC and TIBC in comparison with the rest of the study group. In this group of patients, prohepcidin concentrations were significantly lower than those in other patients. Conclusion: The results indicate that PV patients suffer from iron metabolism disorders. The decreased serum level of prohepcidin in PV patients may be a result of iron deficiency.

Key wordsPolycythemia vera (PV)      Iron metabolism      Prohepcidin      Hepcidin     
Received: 22 July 2009     
CLC:  R55  
Cite this article:

Justyna KWAPISZ, Ewa ŻEKANOWSKA, Joanna JASINIEWSKA. Decreased serum prohepcidin concentration in patients with polycythemia vera. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2009, 10(11): 791-795.

URL:

http://www.zjujournals.com/xueshu/zjus-b/10.1631/jzus.B0920217     OR     http://www.zjujournals.com/xueshu/zjus-b/Y2009/V10/I11/791

[1] Zhang-biao Long, Yong-wei Wang, Chen Yang, Gang Liu, Ya-li Du, Guang-jun Nie, Yan-zhong Chang, Bing Han. Identification of FECH gene multiple variations in two Chinese patients with erythropoietic protoporphyria and a review[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2016, 17(10): 813-820.
[2] Ji-min Shi, Xu-ying Pei, Yi Luo, Ya-min Tan, Ru-xiu Tie, Jing-song He, Wei-yan Zheng, Jie Zhang, Zhen Cai, Mao-fang Lin, He Huang. Invasive fungal infection in allogeneic hematopoietic stem cell transplant recipients: single center experiences of 12 years[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2015, 16(9): 796-804.
[3] Shailendra Kapoor. Emerging role of berbamine as an anti-cancer agent in systemic malignancies besides chronic myeloid leukemia[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2012, 13(9): 761-762.
[4] Yun Liang, Xi Qiu, Rong-zhen Xu, Xiao-ying Zhao. Berbamine inhibits proliferation and induces apoptosis of KU812 cells by increasing Smad3 activity[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2011, 12(7): 568-574.
[5] Lei Wang, Wei-lai Xu, Hai-tao Meng, Wen-bin Qian, Wen-yuan Mai, Hong-yan Tong, Li-ping Mao, Yin Tong, Jie-jing Qian, Yin-jun Lou, Zhi-mei Chen, Yun-gui Wang, Jie Jin. FLT3 and NPM1 mutations in Chinese patients with acute myeloid leukemia and normal cytogenetics[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2010, 11(10): 762-770.
[6] Hua-feng WANG, Yi-zhi CHENG, Huan-ping WANG, Zhi-mei CHEN, Ji-yu LOU, Jie JIN. CD19-positive acute myeloblastic leukemia with trisomy 21 as a sole acquired karyotypic abnormality[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2009, 10(11): 833-838.
[7] Man-ling WANG, Qiang HUANG, Tian-xin YANG. IgE myeloma with elevated level of serum CA125[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2009, 10(7): 559-562.
[8] LI Yi, DU Bin, PAN Jia-qi, CHEN De-chang, LIU Da-wei. Up-regulation interleukin-6 and interleukin-8 by activated protein C in lipopolysaccharide-treated human umbilical vein endothelial cells[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2006, 7(11): 9-.